(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
Sept 9 (Reuters) - European shares steadied on Wednesday
after hefty declines in the previous session, although sentiment
was rattled by AstraZeneca suspending global trials for its
COVID-19 vaccine.
AstraZeneca Plc AZN.L shares slipped 1.3% as it also
paused large late-stage trials of its experimental vaccine due
to an unexplained illness in a study participant.
The pan-European STOXX 600 index .STOXX edged 0.1% higher
at 0710 GMT, with travel and leisure stocks .SXTP among the
biggest decliners in early trading.